Research News

Full report identifying priorities for future alcohol-related liver disease research published

Friday, 14 July 2017 11:40

The James Lind Alliance (JLA) has published the full report of its Priority Setting Partnership (PSP) identifying priorities for future research into alcohol-related liver disease (ARLD).

The NIHR highlighted the importance of ARLD when it jointly funded the JLA's PSP with the BSG. Now the JLA has released the full details in the report. It includes the list of top 10 research priorities and the remaining unanswered questions that patients, carers and health professionals taking part in the PSP said concerned them the most - both of which were published last year.

But it also explains the process that was followed to reach the agreed list of research priorities and includes more information on the types of people who responded to the survey.

ARLD is the most common type of death caused by alcohol in England - accounting for two-thirds of alcohol-related deaths in 2011 - causing 4,441 (64%) of drink-related fatalities. The disease is the second highest cause of years of life lost in young men and of 65% and 62% of male and female alcohol-related deaths respectively - most among those aged 50-59.

BSG chief executive Richard Gardner said: "The British Society of Gastroenterology is delighted to have supported such an important piece of work with our colleagues at JLA and NIHR.

"ARLD is an area of significant unmet patient need where outcomes are far below what we would like to see.

"Identifying the key research questions in this important area was a priority for the Society and we are hopeful that the high quality research questions identified will lead to funding to support new innovations and improvements for patients with ARLD."

Research Priorities for Alcohol-Related Liver Disease

Friday, 23 June 2017 13:54

Alcohol-related liver disease accounts for the majority of UK liver disease, which is the third most common cause of premature death in the UK. It has had disproportionately little research attention or spending in the past, despite its impact on patients and their families, and there are still many questions about the diagnosis, treatment and care of the disease that remain unanswered.

Traditionally, the focus of medical research is decided by funders and researchers. There is often a mismatch between what gets researched and what would actually make a real difference to the lives of patients. The James Lind Alliance (JLA) offers a process to ask patients, carers and health professionals to identify and then prioritise the unanswered questions that concern them most. In 2014, the National Institute for Health Research (NIHR) asked the JLA to run a Priority Setting Partnership (PSP) to find unanswered questions about the prevention, diagnosis, treatment and care of alcohol-related liver disease that are important to the people it affects. This is the first known PSP involving an alcohol-related condition.

This report explains the process that was followed to reach the agreed list of research priorities, what the priorities were and who was involved to make sure that it was independent and fair

BSG 2017 Prize Winners

Friday, 30 June 2017 10:11

The BSG congratulates all winners of poster presentations, oral communications and journal prizes for their hard work. All winners receive a certificate. Poster winners receive £100; oral communication winners receive £250. Poster and oral communication prizes are funded by the BSG Research Committee's budget. Journal prize winners were awarded on an individual basis, as outlined below. The details of winning presentations are listed further below. Abstracts are available by logging into the BSG website or using the Gut journal link.

The winner of the BMJ Open Gastroenterology prize for the "Best clinical science abstract for oral presentation" was chosen by Dr Joseph Lim (Editor) and presented on his behalf by Prof Emad El-Omar to Dr Megan Rossi, King's College London for OC-024: "Volatile organic compounds predict response to both low FODMAP diet and probiotics in irritable bowel syndrome: a randomised controlled trial". This Oral Communication was presented during the Small Bowel & Nutrition free papers symposium on Tuesday 20 June 2017. Dr Rossi won an article processing charge waiver for BMJOG.

The winner of the Frontline Gastroenterology prize for "Best patient benefit in gastroenterology" was chosen by Dr Anton Emmanuel (Editor) and team. The prize was presented by Dr Emmanuel to Dr Theresa Hydes, Portsmouth Hospitals NHS Trust for OC-013: "The National Early Warning Score (NEWS) accurately discriminates the risk of serious in-hospital adverse outcomes in patients with liver disease". This Oral Communication was presented during the Liver free papers symposium on Tuesday 20 June 2017. Dr Hydes won £250.

The winner of the Gut prize for the "Best basic science abstract for oral presentation" was chosen by Prof Emad El-Omar (Editor), who presented the prize to Dr Rimma Goldberg, Guy's and St Thomas' Hospital, London for OC-066: "Gut specific regulatory T cells - a new frontier for Crohn's Disease therapy". This Oral Communication was presented during the IBD Section Symposium: New Insights into Biologics on Wednesday 21 June 2017. Dr Goldberg won £350.

Crohn's and Colitis UK Panel Member Vacancies

Friday, 16 June 2017 14:38

Applications are invited seeking new Panel Members to fill the following vacancies on two Research Awards Panels:

  • Up to 3 new clinical/academic members on our Medical Research Awards Panel (including a basic scientist);
  • A surgeon; and
  • A health services researcher.

These are voluntary positions (reasonable expenses paid) requiring a commitment of two meetings a year - in early November (teleconference) and March (London).

Our Awards Panels play a key role in reviewing, assessing and shortlisting the grant applications we receive for funding. The quality of our Panels and peer review process (certified as best practice by the AMRC) make it possible for us to fund the highest quality research in the field of IBD.

Panel Members are not precluded from applying for funding but if they do apply, they must disclose a conflict of interest and cannot be party to any discussions or decisions concerning their application.

Closing date for applications is 4pm on Tuesday, 1st August 2017.

Further information and a recruitment pack is available from or contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or on 01727 734 468.

Page 3 of 38